SIportfolio

Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio Grand Rapids, MI – September 22, 2025 – Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem (“InSet™ 70”). The […]

GRAND RAPIDS, Mich., Sept. 9, 2025 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2025. Recent Business Highlights “We are pleased with both our second quarter performance, which was in-line

Grand Rapids, MI – March 10, 2025 – Shoulder Innovations, a cultivate(MD) portfolio company, and a leader in shoulder replacement technology, today announced the closing of a $40 million Series E equity financing round. The financing was led by existing investor U.S. Venture Partners (USVP), with support from additional existing investors including Gilde Healthcare Partners, Gilmartin Capital,

Grand Rapids, MI – July 24, 2024 – Shoulder Innovations, a cultivate(MD) portfolio company and leader in shoulder replacement technology, today announced the United States Patent and Trademark Office (USPTO) has granted nine new patents over the past 18 months that significantly expand the Company’s intellectual property portfolio. The newly granted patents cover key areas within

Grand Rapids, Mich., September 29, 2023—Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market announced today that they have hired Mr. Jeff Points as Chief Financial Officer. Mr. Points has 25 years of finance experience in high-growth organizations, most recently as Chief Financial Officer at Cardiovascular Systems where he